SARSVAX: DNA-based vaccine to prevent COVID-19
Instituto de Salud Carlos III, Madrid, Spain
There are currently no vaccines available for the prevention of infections caused by the SARS-CoV-2 coronavirus. In this project, a DNA-based vaccine will be designed using technology previously developed at the National Centre for Microbiology of the Instituto de Salud Carlos III.
Prophylactic vaccination can provide protection from infection on a population scale, thus removing the need to implement social distancing measures in protected populations. The societal impact of an effective vaccine for COVID-19 would therefore be very high on both health and economic levels.